Projects per year
Fingerprint
Collaborations and top research areas from the last five years
Profiles
-
JAK2 inhibitors: JAK2 inhibitors and the innate immune response in mutant CALR-driven MPNs
Stoiber-Sakaguchi, D. (PI), Podar, K. (CoPI) & Kollmann, K. (CoPI)
Gesellschaft für Forschungsförderung NÖ (GFF)
01.01.2022 → 31.12.2026
Project: Funded Research
-
APOG: ACCESS POINT Oncology
Podar, K. (PI), Stoiber-Sakaguchi, D. (CoPI), Pecherstorfer, M. (CoPI), Georg, P. (CoPI), Kieseberg, P. (CoPI), Fossati, P. (CoPI), Lütgendorf-Caucig, C. (CoPI) & Slade, D. (CoPI)
01.01.2020 → 31.12.2026
Project: Funded Research
-
STAT3: STAT3 isoforms in hematopoietic disorders
Stoiber-Sakaguchi, D. (PI), Podar, K. (CoPI) & Casanova, E. (CoPI)
Gesellschaft für Forschungsförderung NÖ (GFF)
01.01.2021 → 31.12.2024
Project: Funded Research
Research output
-
A Novel CDK9 inhibitor, GT-02897, selectively induces cytotoxic effects and exhibits preclinical
Aksoy, O., 08 Jun 2026.Research output: Contribution to conference › Poster at a conference
-
A Novel CDK9 inhibitor, GT-02897, selectively induces cytotoxic effects and exhibits preclinical synergistic activity in Myeloma
Aksoy, O., 11 Jun 2026.Research output: Contribution to conference › Poster at a conference
-
A novel combination approach targeting P300 and DNA-PK exploits epigenetic dependencies in acute myeloid leukemia
Saladi, S. V., Garg, S., Weisberg, E. L., Case, A. E., Ni, W., Pareek, S., Podar, K., Salgia, R., Griffin, J. D., Stone, R. M. & Sattler, M., 01 Sept 2026, In: Molecular Therapy Oncology. 34, 3, p. 201262Research output: Journal article (peer-reviewed) › Journal article
Open Access
-
PhD TUMOR BIOLOGY - Akkreditierung AQ AustriaKrems
Meli, R. (Participant)
10 Feb 2026Activity: Participating in/organising an event › Organising an event (Science to science)
-
1st Lower Austrian Conference on Cancer Research
Podar, K. (Organiser) & Vallet, S. (Co-Organiser)
13 Nov 2025Activity: Participating in/organising an event › Organising an event (Science to science)
-
41st Research KiK
Meli, R. (Speaker)
29 Oct 2025Activity: Participating in/organising an event › Organising an event (Science to science)
Prizes
-
Delineating CDK9-regulated molecular events for the development of rationally derived multiple myeloma treatment strategies
Aksoy, O. (Recipient), Apr 2023
Prize: Other distinction › Other
-
Impact of Immune Checkpoint Inhhibitors on Bone Turnover in Cancer Patients: Prospective Clinical Study and Preclinical Correlates
Gassner, T. (Recipient), Apr 2023
Prize: Other distinction › Poster prize
-
Wissenschaftspreis des Landes Niederösterreich 2022
Vallet, S. (Recipient), 2022
Prize: Honorary award
Student theses
-
A retrospective study of adverse events in patients treated with immune-checkpoint inhibitors
Kvalsvik, E. (Author), Vallet, S. (Supervisor), 2022Student thesis: Doctoral Thesis
-
Effects of Immune Checkpoint-Inhibitors on Bone Metabolism in Patients with advanced-staged Carcinomas without Evidence of Bone Metastasis
Pirich , T. (Author), Vallet, S. (Supervisor), 2021Student thesis: Doctoral Thesis
-
In Vitro Evaluation of the Effects of Immune Checkpoint Inhibitors on Bone Cell
Chittilappilly, C. (Author), Vallet, S. (Supervisor), 2024Student thesis: Doctoral Thesis